Petros Pharmaceuticals, Inc. Retained Earnings
Petros Pharmaceuticals, Inc. (PTPI) had Retained Earnings of -$113.24 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$113.24M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$112.28M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$111.29M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$110.96M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$113.24M 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$112.28M 10-Q · filed 2026-05-13 |
| 2025-12-31 | -$111.29M 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$110.96M 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$110.04M 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$115.47M 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$113.21M 10-K · filed 2026-04-15 |
| 2024-09-30 | -$103.93M 10-Q · filed 2024-11-13 |
| 2024-06-30 | -$101.71M 10-Q · filed 2024-08-14 |
| 2024-03-31 | -$101.05M 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$98.89M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$99.21M 10-Q · filed 2023-11-15 |
| 2023-06-30 | -$94.66M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$92.11M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$90.73M 10-K · filed 2024-04-01 |
| 2022-09-30 | -$86.51M 10-Q/A · filed 2022-11-15 |
| 2022-06-30 | -$72.67M 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$70.86M 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$70.69M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$62.50M 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$60.81M 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$58.69M 10-Q · filed 2021-05-14 |
| 2020-12-31 | -$61.70M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |